NanJing Pharmaceutical Company Limited (600713.SS)
CNY 5.2
(-0.38%)
CNY 5.2
(-0.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 53.58 Billion | 50.22 Billion | 45.12 Billion | 39.81 Billion | 37.15 Billion | 31.3 Billion |
| Cost of Revenue | 50.27 Billion | 46.96 Billion | 42.18 Billion | 37.28 Billion | 34.69 Billion | 29.23 Billion |
| Gross Profit | 3.31 Billion | 3.25 Billion | 2.93 Billion | 2.53 Billion | 2.45 Billion | 2.06 Billion |
| Operating Expenses | 2.3 Billion | 1.75 Billion | 1.6 Billion | 1.41 Billion | 1.45 Billion | 1.26 Billion |
| Selling, General and Administrative Expenses | 1.67 Billion | 1.23 Billion | 1.12 Billion | 1 Billion | 1.03 Billion | 886.84 Million |
| Research and Development Expenses | 36.18 Million | 27.43 Million | 20.95 Million | 15.99 Million | 13.35 Million | 6.43 Million |
| Other Expenses | 588.93 Million | 497.32 Million | 455.16 Million | 389.27 Million | 402.38 Million | -3.93 Million |
| Cost and Expenses | 52.58 Billion | 48.72 Billion | 43.79 Billion | 38.69 Billion | 36.15 Billion | 30.49 Billion |
| Operating Income | 1.49 Billion | 1.32 Billion | 1.23 Billion | 1.03 Billion | 1.06 Billion | 479.73 Million |
| Interest Expense | 544.88 Million | 332.9 Million | 438.99 Million | 369.9 Million | 447.98 Million | 357.54 Million |
| Income Tax Expense | 265.25 Million | 190.09 Million | 228.31 Million | 207.76 Million | 157.31 Million | 129.96 Million |
| Earnings before Tax | 978.06 Million | 906.01 Million | 838.86 Million | 677.79 Million | 588.87 Million | 475.79 Million |
| Net Income | 577.82 Million | 595.66 Million | 505.18 Million | 376.41 Million | 346.92 Million | 264.29 Million |
| Earnings Per Share Basic | 0.45 | 0.48 | 0.49 | 0.36 | 0.33 | 0.26 |
| Earnings Per Share Diluted | 0.45 | 0.48 | 0.49 | 0.36 | 0.33 | 0.26 |
| Weighted Average Shares Outstanding | 1.29 Billion | 1.25 Billion | 1.04 Billion | 1.04 Billion | 1.04 Billion | 1.01 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.29 Billion | 1.25 Billion | 1.04 Billion | 1.04 Billion | 1.04 Billion | 1.01 Billion |
| Gross Margin | 0.06 | 0.06 | 0.07 | 0.06 | 0.07 | 0.07 |
| EBIT Margin | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Profit Margin | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EBITDA | 1.61 Billion | 1.62 Billion | 1.54 Billion | 1.16 Billion | 1.19 Billion | 966.5 Million |
| Earnings Before Tax Margin | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 13.67 Billion | 13.27 Billion | 13.92 Billion | 13 Billion | 53.48 Billion | 13.2 Billion |
| Cost of Revenue | 12.86 Billion | 12.44 Billion | 13.11 Billion | 12.26 Billion | 50.55 Billion | 12.37 Billion |
| Gross Profit | 813.86 Million | 838.54 Million | 815.25 Million | 746.59 Million | 2.93 Billion | 826.5 Million |
| Operating Expenses | 465.26 Million | 417.35 Million | 430.28 Million | 370.7 Million | 1.43 Billion | 447.69 Million |
| Selling, General and Administrative Expenses | 459.81 Million | 230.19 Million | 419.58 Million | 362.11 Million | - | 612.99 Million |
| Research and Development Expenses | 8.24 Million | 12.05 Million | 10.23 Million | 6.28 Million | - | 10.6 Million |
| Other Expenses | 2.79 Million | -256.39 Million | -467.14 Thousand | -2.3 Million | -6.09 Million | -8.66 Million |
| Cost and Expenses | 13.32 Billion | 12.85 Billion | 13.54 Billion | 12.63 Billion | 51.98 Billion | 12.82 Billion |
| Operating Income | 348.6 Million | 281.98 Million | 384.96 Million | 375.89 Million | 1.49 Billion | 219.32 Million |
| Interest Expense | 95.98 Million | - | 88.83 Million | 89.94 Million | 378.49 Million | 20.44 Million |
| Income Tax Expense | 55.4 Million | 78.07 Million | 65.26 Million | 66.04 Million | 265.25 Million | 53.48 Million |
| Earnings before Tax | 221.43 Million | 278.66 Million | 262.27 Million | 246.07 Million | 972 Million | 210.65 Million |
| Net Income | 130.56 Million | 152.23 Million | 159.08 Million | 137.53 Million | 577.82 Million | 131.65 Million |
| Earnings Per Share Basic | 0.10 | 0.12 | 0.12 | 0.11 | - | 0.10 |
| Earnings Per Share Diluted | 0.10 | 0.12 | 0.12 | 0.11 | - | 0.10 |
| Weighted Average Shares Outstanding | 1.29 Billion | 1.29 Billion | 1.29 Billion | 1.29 Billion | 1.29 Billion | 1.29 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.29 Billion | 1.29 Billion | 1.29 Billion | 1.29 Billion | 1.29 Billion | 1.29 Billion |
| Gross Margin | 0.06 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 |
| EBIT Margin | 0.02 | 0.01 | 0.03 | 0.03 | - | 0.02 |
| Profit Margin | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EBITDA | 317.42 Million | 195.66 Million | 383.48 Million | 446.19 Million | - | 262.14 Million |
| Earnings Before Tax Margin | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 |
603138
MFG
MADHAV
HELIO
001313
ANDHRAPET